Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

    Study mitochondria, aging, HIV, and substance use to develop therapies for healthier aging in HIV and addiction patients.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV

    This grant supports research to identify and validate new, modifiable therapeutic targets for improving central nervous system outcomes in people with HIV using patient data and innovative models.

    HHS-NIH11Due Oct 28, 2027

    Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

    This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.

    HHS-NIH11Forecasted Jun 8, 2027$1,000,000Forecasted

    HIV Age Positively

    HIV Age Positively by Gilead Sciences funds research and programs to improve health and care for people aging with HIV, focusing on care coordination, resources, and advocacy.

    GileadForecasted Jan 1, 2027$35,800,000Forecasted

    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

    This grant aims to support innovative research on the intersection of HIV and substance use, with the goal of advancing prevention, treatment, and cure efforts among people who use drugs. It is open to both individuals and research teams, covering a wide range of research areas.

    HHS-NIH11Due Feb 5, 2027$7,500,000